Literature DB >> 6600433

Effects of dexamethasone on proliferation of autologous fibroblasts and on the immune profile in women undergoing pelvic surgery for infertility.

M Granat, J G Schenker, S Mor-Yosef, E Rosenkovitch, R C Castellanos, U Galili.   

Abstract

Dexamethasone (DEX) was administered postoperatively to six patients undergoing lysis of pelvic adhesions. During therapy the proportion of T cells among the peripheral blood lymphocytes sharply declined from 60% to 20%. Response to T- and B-cell mitogens decreased to 20% to 40% of the original response prior to surgery. DEX-containing serum had an enhancing effect on the growth of autologous fibroblasts derived from pelvic adhesions (50% more than the effect of pretreatment serum). Pure cortisol and DEX induced a similar enhanced growth. The enhancing ability of the patients' sera disappeared 48 hours after discontinuation of DEX, corresponding to the recovery of the lymphoid system. If there is any benefit in steroid treatment to prevent pelvic adhesion formation, it is apparently not via an inhibitory effect on fibroblast proliferation. Such treatment, however, clearly suppresses the immune response of the patients during the early postoperative course.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600433     DOI: 10.1016/s0015-0282(16)46816-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  New concepts in suture selection and technical approaches in gynecological surgery.

Authors:  R Duvivier
Journal:  Bull N Y Acad Med       Date:  1985-09

2.  Effect of dexamethasone on serum transcobalamin II concentration in women undergoing pelvic surgery.

Authors:  M Granat; B Rachmilewitz; S Mor-Yosef; J G Schenker; M Rachmilewitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.

Authors:  Tal Tamari; Rina Elimelech; Gal Cohen; Talia Cohen; Ofri Doppelt; Lana Eskander-Hashoul; Hadar Zigdon-Giladi
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.